Sign In
Buy ABT
$93.24
+2.73 (+3.02%)
At Close: Jun 25, 2026
2 Healthcare Stocks to Buy in a Bear Market
09:15am, Saturday, 03'rd Jan 2026
Johnson & Johnson and Abbott Laboratories are diversified healthcare companies with attractive prospects. Both have raised their dividends for over 50 consecutive years.
American National Bank & Trust Has $939,000 Stock Position in Abbott Laboratories $ABT
05:03am, Saturday, 03'rd Jan 2026
American National Bank and Trust lessened its stake in shares of Abbott Laboratories (NYSE: ABT) by 39.9% during the undefined quarter, according to the company in its most recent filing with the Secu
Altfest L J & Co. Inc. Decreases Stake in Abbott Laboratories $ABT
04:01am, Saturday, 03'rd Jan 2026
Altfest L J and Co. Inc. reduced its stake in shares of Abbott Laboratories (NYSE: ABT) by 34.0% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Comm
Bank Pictet & Cie Europe AG Has $9.82 Million Stock Position in Abbott Laboratories $ABT
03:28am, Friday, 02'nd Jan 2026
Bank Pictet and Cie Europe AG cut its stake in Abbott Laboratories (NYSE: ABT) by 19.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commis
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock
10:01am, Wednesday, 31'st Dec 2025
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Best Dividend Aristocrats For January 2026
08:47am, Wednesday, 31'st Dec 2025
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%
Abbott Laboratories $ABT Stock Holdings Boosted by Calamos Wealth Management LLC
05:34am, Wednesday, 31'st Dec 2025
Calamos Wealth Management LLC lifted its position in Abbott Laboratories (NYSE: ABT) by 90.1% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor
Diversified Trust Co Boosts Stake in Abbott Laboratories $ABT
05:10am, Tuesday, 30'th Dec 2025
Diversified Trust Co grew its holdings in Abbott Laboratories (NYSE: ABT) by 25.1% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange
Abbott Laboratories (NYSE:ABT) Given Consensus Rating of “Moderate Buy” by Analysts
01:32am, Tuesday, 30'th Dec 2025
Shares of Abbott Laboratories (NYSE: ABT - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twenty-three research firms that are presently covering the stock, Market
Sowell Financial Services LLC Lowers Holdings in Abbott Laboratories $ABT
06:28am, Monday, 29'th Dec 2025
Sowell Financial Services LLC lowered its stake in shares of Abbott Laboratories (NYSE: ABT) by 24.8% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 17,966
HBK Sorce Advisory LLC Sells 5,406 Shares of Abbott Laboratories $ABT
05:36am, Monday, 29'th Dec 2025
HBK Sorce Advisory LLC trimmed its position in Abbott Laboratories (NYSE: ABT) by 22.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchang
Best Dividend Kings: December 2025
06:44am, Sunday, 28'th Dec 2025
Dividend Kings underperformed SPY in 2025, up 4.47% vs. SPY's 17.7%, but select Kings outperformed the index. Twenty-two Dividend Kings are identified as both potentially undervalued and offering long
Abbott Laboratories Shrugs Off Tariffs And China Headwinds With A 7% Dividend Raise
10:00am, Wednesday, 24'th Dec 2025
Abbott Laboratories (ABT) earns a buy rating for its operational resilience, robust fundamentals, and strong dividend growth despite headwinds. ABT delivered double-digit EPS growth, solid Medical Dev
Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors?
07:45am, Wednesday, 24'th Dec 2025
This basket of 64 medical device stocks could raise its dividend for decades.
Abbott Stock May Benefit Following Volt PFA's FDA Approval
03:11pm, Tuesday, 23'rd Dec 2025
ABT wins FDA approval for its Volt PFA System for AFib, paving the way for U.S. launches and EU expansion after earlier CE Mark clearance.
